Targetable Brg1-CXCL14 axis contributes to alcoholic liver injury by driving neutrophil trafficking

Nan Li1, Hong Liu1, Yujia Xue1

  • 1Key Laboratory of Targeted Intervention of Cardiovascular Disease and Collaborative Innovation Center for Cardiovascular Translational Medicine, Department of Pathophysiology, Nanjing Medical University, Nanjing, China.

EMBO Molecular Medicine
|February 1, 2023
PubMed